New hope for a Type 1 diabetes cure being tested


Johnson & Johnson is joining forces with biotech company Viacyte to speed development of the first stem cell treatment that could correct the life-threatening hormonal disorder Type 1 diabetes. They've already begun testing it in a small number of diabetic patients.